Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- (12?)-5,9?,11?-trihydroxy-prosta-6E,14Z-dien-1-oic-16,16,17,17,18,18,19,19,20,20,20-d11 acid
- Correlated keywords
- GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry analogs internal standards isoprostanes prostaglandins free-radical lipid peroxidation stero- regioisomers arachidonic acids 8-isoprostane 8-epi-PGF2.alpha. iPF2.alpha.-III oxidative stress Type VI class internal lactones facilitates extraction and purification neurochemistry neuroscience
- Product Overview:
8,12-iso-isoprostane F2?-VI-d11 (8,12-iso-iPF2?-VI-d11) contains 11 deuterium atoms at the 16, 16′, 17, 17′, 18, 18′, 19, 19′, 20, 20, and 20 positions. It is intended for use as an internal standard for the quantification of 8,12-iso-iPF2?-VI by GC- or LC-mass spectrometry. The relative abundance of deuterium atoms incorporated into each molecule has not been determined. Cayman certifies that less that 1% of the product has no deuterium incorporation (enzymatic, non-cyclooxygenase prostanoid products of peroxidative damage to membrane lipids.{7692} Among the many isoprostane isomers, 8,12-iso-iPF2?-VI has been demonstrated to be one of the predominant isomers formed and is also present in urine as one of the major isoprostane products.{6910} 8,12-iso-iPF2?-VI-d11 is a deuterated internal standard for use in isoprostane quantitation by mass spec modalities. The compound is diastereomeric at C-5, but is otherwise an optically active, single enantiomer.
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.